JLGPX
Price
$76.09
Change
-$1.57 (-2.02%)
Updated
Mar 3 closing price
Net Assets
104.79B
VIGIX
Price
$203.79
Change
-$5.05 (-2.42%)
Updated
Mar 3 closing price
Net Assets
292.14B
Ad is loading...

JLGPX vs VIGIX

Header iconJLGPX vs VIGIX Comparison
Open Charts JLGPX vs VIGIXBanner chart's image
JPMorgan Large Cap Growth R3
Price$76.09
Change-$1.57 (-2.02%)
VolumeN/A
Net Assets104.79B
Vanguard Growth Index Institutional
Price$203.79
Change-$5.05 (-2.42%)
VolumeN/A
Net Assets292.14B
JLGPX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JLGPX vs. VIGIX commentary
Mar 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLGPX is a Hold and VIGIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 292B vs. JLGPX (105B). VIGIX pays higher dividends than JLGPX: VIGIX (0.53) vs JLGPX (0.05). JLGPX was incepted earlier than VIGIX: JLGPX (8 years) vs VIGIX (27 years). JLGPX is a more actively managed with annual turnover of: 42.00 vs. VIGIX (5.00). JLGPX has a lower initial minimum investment than VIGIX: JLGPX (0) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 18.13 vs. JLGPX (12.01). VIGIX return over 5 years is better than : 118.14 vs. JLGPX (82.07).
JLGPXVIGIXJLGPX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years27 years-
Gain YTD-2.286-1.131202%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets105B292B36%
Annual Yield % from dividends0.050.539%
Returns for 1 year12.0118.1366%
Returns for 3 years46.6651.0891%
Returns for 5 years82.07118.1469%
Returns for 10 yearsN/A277.72-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HWBK31.260.52
+1.69%
Hawthorn Bancshares
CVAC3.08-0.02
-0.65%
CureVac NV
ENSC5.32-0.07
-1.30%
Ensysce Biosciences
FOLD9.15-0.35
-3.64%
Amicus Therapeutics
INCY70.35-3.15
-4.29%
Incyte Corp